4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis

Kerstin Goebel, Jan-Hendrik Wedell, Alexander M. Herrmann, Lydia Wachsmuth, Susann Pankratz, Stefan Bittner, Thomas Budde, Christoph Kleinschnitz, Cornelius Faber, Heinz Wiendl, Sven G. Meuth

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)62-71
JournalExperimental Neurology
Volume248
DOIs
Publication statusPublished - Oct 2013

Keywords

  • 4-Aminopyridine
  • Multiple sclerosis
  • EAE
  • Symptomatic treatment
  • Mobility

Cite this

Goebel, K., Wedell, J-H., Herrmann, A. M., Wachsmuth, L., Pankratz, S., Bittner, S., Budde, T., Kleinschnitz, C., Faber, C., Wiendl, H., & Meuth, S. G. (2013). 4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis. Experimental Neurology, 248, 62-71. https://doi.org/10.1016/j.expneurol.2013.05.016